ARTICLES BY ALETHEA WIELAND
-
![Looking OVer Mountain]( "Regulatory Science & Clinical Research: Where Do We Stand (And Where Are We Going)?")
Regulatory Science & Clinical Research: Where Do We Stand (And Where Are We Going)?This article will share some thoughts on the current state of regulatory science, by reflecting back on two prominent meetings — the inaugural UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) Summit and the Clinical Trials Transformation Initiative (CTTI) Virtual Meetings for Stakeholder Engagement on ICH E6.
-
![iStock-1135147682]( "What’s Really Behind The CRA Shortage In Clinical Trials? A Root Cause Analysis")
What’s Really Behind The CRA Shortage In Clinical Trials? A Root Cause AnalysisThe #1 and #2 complaints I hear consistently from peers and partners in life sciences companies are the inability to hold third-party partners and CROs accountable for quality performance and to have a consistent experienced team over the life of their clinical trial. The two are inextricably linked.
Alethea Wieland
Alethea Wieland is founder and president of Clinical Research Strategies, LLC, an executive-level management consulting firm and boutique, functional service provider for the life sciences industry. Her firm’s solutions include analyzing the intersection of healthcare innovation and policy; providing flexible clinical trial resourcing; developing sustainable corporate affairs programs and policies; training and managing resilient, high-performing clinical operations teams; mitigating risks of clinical trials; and facilitating transparent, accountable sponsor-CRO partnerships. Learn more by connecting with her on LinkedIn, and by visiting her website, www.clinicalresearchstrategies.com.